
Decoding Developmental and Epileptic Encephalopathy, 34: The Role of Genetic Testing
Unlock the potential of genetic testing for accurate diagnosis and tailored treatment of Developmental and Epileptic Encephalopathy, 34, enhancing patient care.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Unlock the potential of genetic testing for accurate diagnosis and tailored treatment of Developmental and Epileptic Encephalopathy, 34, enhancing patient care.

Explore how genetic testing aids in diagnosing Developmental and Epileptic Encephalopathy, 35, enabling personalized treatment, prognostic insights, and family planning.

Unlock insights into Developmental and Epileptic Encephalopathy, 37 with genetic testing. Explore its role in early diagnosis, personalized care, and family planning.

Genetic testing revolutionizes DEE38 diagnosis, offering accurate insights, guiding treatments, and aiding family planning by pinpointing GNAO1 gene mutations.

Genetic testing is crucial for early diagnosis of Early-Onset Lafora Body Disease, offering personalized care, informed family planning, and potential treatment insights.

Explore how genetic testing unravels idiopathic generalized epilepsy, focusing on RYR3 gene variants for personalized treatment and disease susceptibility insight.

Explore how genetic testing aids in early diagnosis and personalized treatment of rare Even-Plus Syndrome, addressing HSPA9 mutations for better patient outcomes.

Uncover how genetic testing identifies ETFDH mutations in riboflavin-responsive exercise intolerance, enabling personalized treatment and improved life quality.